[-] Show simple item record

dc.contributor.authorLoomis, Lucy W.eng
dc.date.issued2001-10eng
dc.description.abstractTight control of hypertension treatment is key in preventing the vascular complications of diabetes. ACE inhibitors appear to have a protective effect that is independent of their antihypertensive effect. Unless there is a contraindication, all patients with diabetes who have hypertension should be treated with ACE inhibitors. Patients with diabetes who have microalbuminuria should be treated with ACE inhibitors, even if normotensive, as should those with overt nephropathy. (Grade of recommendation: A, based on randomized controlled trials.)eng
dc.identifier.urihttp://hdl.handle.net/10355/2823eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2001 (MU)eng
dc.relation.ispartofcollectionUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.subjectmicroalbuminuriaeng
dc.subjectretinopathyeng
dc.subjectnephropathyeng
dc.subject.lcshHypertensioneng
dc.subject.lcshAngiotensin-Converting Enzyme Inhibitorseng
dc.subject.lcshDiabetic nephropathieseng
dc.titleWhat are the indications for treatment with angiotensin-converting enzyme (ACE) inhibitors in patients with diabetes?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record